Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026)

Sera Prognostics (SERA) reported Cash from Investing Activities of $9.0 million for Q1 2026, up 120.05% on a YoY basis from $4.1 million in Q1 2025, and up 52.55% quarter-over-quarter from $5.9 million in Q4 2025.

Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Sera Prognostics has reported Cash from Investing Activities for 7 years, with the latest figure at $9.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 120.05% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $25.3 million (up 192.38% YoY), and the FY2025 full-year result was -$28.5 million, down 342.71% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $9.0 million, up from $5.9 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $14.6 million in Q1 2022, with the low at -$44.8 million in Q1 2025.
  • Historically, Cash from Investing Activities has averaged -$105000.0 across 5 years, with a median of $4.9 million in 2024.
  • The largest YoY upside for Cash from Investing Activities was 35792.68% in 2022 against a maximum downside of 1322.35% in 2022.
  • Sera Prognostics' Cash from Investing Activities stood at -$1.6 million in 2022, then jumped by 123.7% to $374000.0 in 2023, then soared by 1874.6% to $7.4 million in 2024, then retreated by 20.24% to $5.9 million in 2025, then soared by 52.55% to $9.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at $9.0 million (Q1 2026), $5.9 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -20.32 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -185.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -2.50 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -298.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -217.20 Mn
10 Sera Prognostics 100.52 Mn 100.52 Mn -28,000.00 8.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.99 Mn
Mar 31, 2026 8.99 Mn
Dec 31, 2025 5.89 Mn
Dec 31, 2025 5.89 Mn
Sep 30, 2025 5.17 Mn
Sep 30, 2025 5.17 Mn
Jun 30, 2025 5.24 Mn
Jun 30, 2025 5.24 Mn
Mar 31, 2025 -44.80 Mn
Mar 31, 2025 -44.80 Mn
Dec 31, 2024 7.39 Mn
Dec 31, 2024 7.39 Mn
Sep 30, 2024 4.90 Mn
Sep 30, 2024 4.90 Mn
Jun 30, 2024 5.15 Mn
Jun 30, 2024 5.15 Mn
Mar 31, 2024 -5.69 Mn
Mar 31, 2024 -5.69 Mn
Dec 31, 2023 374,000.00
Dec 31, 2023 374,000.00